Company news

Pyxis Oncology, Inc. news in 2024

Pyxis Oncology, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201

December 18, 2024

Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data

November 19, 2024

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024

November 11, 2024

Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201

November 10, 2024

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024

August 13, 2024

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference

July 28, 2024

Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger

June 9, 2024

Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

May 29, 2024

Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024

May 13, 2024

Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference

May 8, 2024

Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights

March 26, 2024

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023

March 20, 2024

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA

March 12, 2024

Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024

March 6, 2024

Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting

March 4, 2024

Pyxis Oncology Announces $50 Million Private Placement

February 26, 2024

Decks in 2024